Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: A Collaborative Transplant Study report-Reference-Cited by-同舟云学术

Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: A Collaborative Transplant Study report

Published:2009-08 Issue:8 Volume:70 Page:569-573
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Süsal Caner,Döhler Bernd,Opelz Gerhard

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference10 articles.

1. Kidney graft failure and presensitization against HLA class I and class II antigens;Süsal;Transplantation,2002

2. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I;Süsal;Hum Immunol,2004

3. Renal transplantation performed across a positive crossmatch: A single centre experience;Leavey;Ir J Med Sci,1997

4. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification;Gibney;Nephrol Dial Transplant,2006

5. Clinical operational tolerance after kidney transplantation;Roussey-Kesler;Am J Transplant,2006

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pretransplant, Th17 dominant alloreactivity in highly sensitized kidney transplant candidates;Frontiers in Transplantation;2024-04-08

2. Superiority of Single-Antigen Bead Study in Donor-Specific Antibodies: Determination in Highly Sensitized Patients;Experimental and Clinical Transplantation;2024-01

3. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation;Transplant Immunology;2023-12

4. Preventing Rejection of the Kidney Transplant;Journal of Clinical Medicine;2023-09-13

5. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) – A single-center experience;Transplant Immunology;2022-10